AB146008
CHC, Monocarboxylic acid transport inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 189.17 g/mol, Purity >98%. Monocarboxylic acid transport (MCT) inhibitor. Exhibits antitumoral and antiangiogenic activity in gliomas in vivo. Decreases glycolytic metabolism, migration, and invasion in U251 cells. Enhances the effect of the DNA-methylating antitumor agent temozolomide (ab141055).
1 Images
- Chemical Structure
Lab
Chemical Structure - CHC, Monocarboxylic acid transport inhibitor (AB146008)
2D chemical structure image of ab146008, CHC, Monocarboxylic acid transport inhibitor
Complementary Products
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Toxicology in vitro : an international journal pub 59:246-254 PubMed31009676
2019
Fibroblast growth factor 21 secretion enhances glucose uptake in mono(2-ethylhexyl)phthalate-treated adipocytes.
Applications
Unspecified application
Species
Unspecified reactive species
Jhih-Wei Hsu,Szu-Ching Yeh,Feng-Yuan Tsai,Hsin-Wei Chen,Tsui-Chun Tsou
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com